STOCK TITAN

Farallon group discloses 9.6% GRAIL, Inc. (GRAL) holding in Schedule 13G/A

(Neutral)
(Neutral)
Form Type
SCHEDULE 13G/A

Rhea-AI Filing Summary

Farallon Capital Management, L.L.C. and affiliated funds report significant ownership in GRAIL, Inc. common stock under a Schedule 13G/A. Acting as investment manager to a group of investment partnerships referred to as the Farallon Funds, Farallon and a group of individual managing members (the Farallon Individual Reporting Persons) report aggregate beneficial ownership of 4,161,584 Shares, representing 9.6% of GRAIL’s outstanding common stock.

The Farallon Funds directly hold 3,590,563 Shares and 571,021 Pre-Funded Common Stock Purchase Warrants, each warrant currently treated as exercisable into one Share for beneficial ownership purposes. These Warrants are subject to a 9.99% Beneficial Ownership Limitation, which the group states does not currently restrict exercise of any Warrants. The Farallon Funds retain the right to receive dividends and sale proceeds on the securities they hold.

Positive

  • None.

Negative

  • None.
Direct common shares held 3,590,563 Shares Common stock of GRAIL, Inc. held by the Farallon Funds
Pre-funded warrants held 571,021 Warrants Pre-Funded Common Stock Purchase Warrants, each exercisable for one Share
Total beneficial ownership 4,161,584 Shares Aggregate Shares beneficially owned by the reporting persons
Ownership percentage 9.6% Percent of GRAIL, Inc. common stock class beneficially owned
Beneficial Ownership Limitation 9.99% Maximum ownership level allowed post-warrant exercise under warrant terms
Pre-Funded Common Stock Purchase Warrants financial
"571,021 Pre-Funded Common Stock Purchase Warrants (the "Warrants"), each of which is exercisable"
A pre-funded common stock purchase warrant is a contract that gives an investor the right to receive a company’s common shares later after having paid nearly the full share price up front, leaving only a very small remaining payment to convert the warrant into an actual share. Think of it like reserving a product by paying almost everything now and paying a tiny balance later; it provides immediate capital to the company, limits immediate dilution of outstanding shares, and lets investors manage ownership limits and timing of when they actually hold tradable stock.
Beneficial Ownership Limitation regulatory
"may not be exercised to the extent that... more than 9.99%... (the "Beneficial Ownership Limitation")"
A beneficial ownership limitation is a rule that caps the percentage of a company’s shares an investor can be treated as owning or controlling for voting, regulatory or tax purposes. It matters to investors because it can restrict how many shares a person or group can buy or vote, affect takeover chances, and influence share liquidity and value — like a speed limit that prevents any single driver from taking over the whole road.
beneficially owned financial
"the securities reported hereby as beneficially owned by the Reporting Persons are held directly"
Beneficially owned describes securities or assets where a person has the economic rights and control—such as the right to receive dividends and to direct voting—even if legal title is held in another name. Think of it like having the keys and using a car that’s registered to someone else: you get the benefits and make decisions. Investors care because beneficial ownership reveals who truly controls value and voting power, affecting corporate decisions and takeover dynamics.
Schedule 13G/A regulatory
"Joint Acquisition Statement Pursuant to Section 240.13d-1(k)"
A Schedule 13G/A is an amended public filing with the U.S. securities regulator that updates a previous Schedule 13G, disclosing when an individual or group holds a substantial (typically over 5%) stake in a company and is claiming a passive, non‑controlling intent. Investors monitor these updates because rising or falling holdings can signal changing confidence, potential future moves, or shifts in voting power — like watching a public ledger where large shareholders quietly adjust their positions.

FAQ

What stake in GRAIL, Inc. (GRAL) does Farallon report on this Schedule 13G/A?

Farallon and affiliated reporting persons report beneficial ownership of 4,161,584 Shares of GRAIL, Inc. common stock, representing 9.6% of the class, including both common shares and shares underlying pre-funded warrants.

How many GRAIL (GRAL) common shares do the Farallon Funds directly hold?

The Farallon Funds directly hold 3,590,563 Shares of GRAIL common stock. These shares are owned across multiple investment partnerships for which Farallon Capital Management, L.L.C. serves as investment manager.

How many GRAIL (GRAL) pre-funded warrants are included in Farallon’s 13G/A filing?

The Farallon Funds hold 571,021 Pre-Funded Common Stock Purchase Warrants. Each warrant is treated as exercisable into one Share for beneficial ownership calculations, subject to a stated Beneficial Ownership Limitation.

What is the Beneficial Ownership Limitation described for GRAIL (GRAL) warrants?

The warrants include a 9.99% Beneficial Ownership Limitation, preventing exercises that would push beneficial ownership above 9.99% of outstanding Shares. Farallon states this limitation does not currently restrict exercising any of the held warrants.

Who are the reporting persons in the GRAIL (GRAL) Schedule 13G/A tied to Farallon?

Reporting persons include Farallon Capital Management, L.L.C. as investment manager and multiple managing members such as Joshua J. Dapice and others, collectively referred to as the Farallon Individual Reporting Persons.

Do the Farallon Funds receive dividends and sale proceeds from their GRAIL (GRAL) holdings?

Yes. The filing states the Farallon Funds have the right to receive dividends and sale proceeds from the GRAIL securities that are beneficially owned by the reporting persons.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates





384747101

(CUSIP Number)
06/30/2026

(Date of Event Which Requires Filing of this Statement)


Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)




schemaVersion:


SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G



Farallon Capital Management, L.L.C.
Signature:/s/ Hannah E. Dunn
Name/Title:Managing Member
Date:08/13/2026
Farallon Capital Partners, L.P.
Signature:/s/ Hannah E. Dunn
Name/Title:Managing Member of its General Partner
Date:08/13/2026
Farallon Capital Institutional Partners, L.P.
Signature:/s/ Hannah E. Dunn
Name/Title:Managing Member of its General Partner
Date:08/13/2026
Farallon Capital Institutional Partners II, L.P.
Signature:/s/ Hannah E. Dunn
Name/Title:Managing Member of its General Partner
Date:08/13/2026
Farallon Capital Institutional Partners III, L.P.
Signature:/s/ Hannah E. Dunn
Name/Title:Managing Member of its General Partner
Date:08/13/2026
Four Crossings Institutional Partners V, L.P.
Signature:/s/ Hannah E. Dunn
Name/Title:Manager of its General Partner
Date:08/13/2026
Farallon Capital Offshore Investors II, L.P.
Signature:/s/ Hannah E. Dunn
Name/Title:Managing Member of its General Partner
Date:08/13/2026
Farallon Capital (AM) Investors, L.P.
Signature:/s/ Hannah E. Dunn
Name/Title:Managing Member of its General Partner
Date:08/13/2026
Farallon Capital F5 Master I, L.P.
Signature:/s/ Hannah E. Dunn
Name/Title:Manager of its General Partner
Date:08/13/2026
Farallon Healthcare Partners Master, L.P.
Signature:/s/ Hannah E. Dunn
Name/Title:Manager of its General Partner
Date:08/13/2026
Farallon Partners, L.L.C.
Signature:/s/ Hannah E. Dunn
Name/Title:Managing Member
Date:08/13/2026
Farallon Institutional (GP) V, L.L.C.
Signature:/s/ Hannah E. Dunn
Name/Title:Manager
Date:08/13/2026
Farallon F5 (GP), L.L.C.
Signature:/s/ Hannah E. Dunn
Name/Title:Manager
Date:08/13/2026
Farallon Healthcare Partners (GP), L.L.C.
Signature:/s/ Hannah E. Dunn
Name/Title:Manager
Date:08/13/2026
Dapice Joshua J.
Signature:/s/ Hannah E. Dunn
Name/Title:Attorney-In-Fact
Date:08/13/2026
Dreyfuss, Philip D.
Signature:/s/ Hannah E. Dunn
Name/Title:Attorney-In-Fact
Date:08/13/2026
Dunn Hannah E.
Signature:/s/ Hannah E. Dunn
Name/Title:Hannah E. Dunn
Date:08/13/2026
Gehani, Varun N.
Signature:/s/ Hannah E. Dunn
Name/Title:Attorney-In-Fact
Date:08/13/2026
Giauque, Nicolas
Signature:/s/ Hannah E. Dunn
Name/Title:Attorney-In-Fact
Date:08/13/2026
Husen, Avner A.
Signature:/s/ Hannah E. Dunn
Name/Title:Attorney-In-Fact
Date:08/13/2026
Kim, David T.
Signature:/s/ Hannah E. Dunn
Name/Title:Attorney-In-Fact
Date:08/13/2026
Linn, Michael G.
Signature:/s/ Hannah E. Dunn
Name/Title:Attorney-In-Fact
Date:08/13/2026
Luo Patrick (Cheng)
Signature:/s/ Hannah E. Dunn
Name/Title:Attorney-In-Fact
Date:08/13/2026
Roberts, Jr., Thomas G.
Signature:/s/ Hannah E. Dunn
Name/Title:Attorney-In-Fact
Date:08/13/2026
Saito Edric C.
Signature:/s/ Hannah E. Dunn
Name/Title:Attorney-In-Fact
Date:08/13/2026
Short Daniel S.
Signature:/s/ Hannah E. Dunn
Name/Title:Attorney-In-Fact
Date:08/13/2026
Spokes, Andrew J. M.
Signature:/s/ Hannah E. Dunn
Name/Title:Attorney-In-Fact
Date:08/13/2026
Warren, John R.
Signature:/s/ Hannah E. Dunn
Name/Title:Attorney-In-Fact
Date:08/13/2026
Wehrly, Mark C.
Signature:/s/ Hannah E. Dunn
Name/Title:Attorney-In-Fact
Date:08/13/2026

Comments accompanying signature: Each of Farallon Partners, L.L.C., Farallon Institutional (GP) V, L.L.C., Farallon F5 (GP), L.L.C, and Farallon Healthcare Partners (GP), L.L.C. has executed this statement in Mill Valley, California, on behalf of itself and each fund for which it is the general partner.
Exhibit Information

Exhibit 1. Joint Acquisition Statement Pursuant to Section 240.13d-1(k)